Doctors are advising men aged 40 and over to undergo regular Prostate-Specific Antigen (PSA) testing as a preventative measure for prostate cancer. Early detection through PSA screening significantly improves treatment outcomes and chances of recovery. Delaying screening until symptoms appear often leads to later-stage diagnoses, resulting in higher treatment costs and increased risk of complications. The recommendation aims to shift the focus from reactive treatment of advanced cases to proactive identification of the disease in its initial stages. Regular testing allows for timely intervention and potentially less invasive treatment options. This preventative approach is considered crucial for improving the health and well-being of men over 40.